期刊文献+

荧光原位杂交技术在多发性骨髓瘤中的应用 被引量:2

Clinical practice of fluorescence in situ hybridization in multiple myeloma
下载PDF
导出
摘要 目的 了解多发性骨髓瘤常见染色体异常情况,探讨其与临床分期及免疫学分型的关系。方法 对39例多发性骨髓瘤初诊患者进行1q21、RBl、D13S319、p53及IGH5种基因探针荧光原位杂交检测1q21扩增、13q14缺失、p53缺失以及IGH基因重排的发生率,统计分析染色体异常情况与临床分期及免疫学分型的关系。结果 1q21、RBl、D13S319、p53及IGH探针的阳性阈值分别为:7.2%、8.7%、7.9%、7.2%和9.8%。39例患者中,1q21扩增24例(61.5%);13q14缺失18例(46.2%),其中同时检出D13S319和RBl缺失15例;p53缺失8例(20.5%);IGH基因重排13例(33.3%)。除IGH重排与D-S分期之间(r=0.434,P=0.007)、p53缺失与IIS分期之间(r=-0.448,P=0.006)和D13S319缺失与免疫学分型之间(r=-0.335,P=0.040)呈显著相关性外,其余染色体异常与临床分期和免疫学分型均无相关性。结论 1q21扩增、13q14缺失、p53基因缺失及IGH重排是多发性骨髓瘤常见的核型异常,FISH检测技术有助于探索染色体异常与多发性骨髓瘤发展及预后的关系。 Objective To investigate the familiar genetic abnormality in MM patients and its relationship with clinical features and immunological types.Methods In 39 cases of MM,the incidence of lq21 amplification,13q14 deletion,p53 gene deletion and 14q32 rearrangement were detected with the five sequence-specific DNA probes(lq21,RBl,D13S319,p53 and IGH)by FISH,and the correlations between these chromosome abnormality to clinical states and immunological types were analyzed.Results The threshold value of lq21,RBl,D13S319,p53 and IGH were 7.2%,8.7%,7.9%,7.2% and 9.8% respectively.In 39 cases of MM,24 cases(61.5%)showed lq21 amplification;18 cases(46.2%)showed 13q14 deletion,while 15 cases were deletion of both RB1 and D13S319;8 cases(20.5%)showed p53 gene deletion;13 cases(33.3%)showed IGH gene rearrangement.There was no correlation except between the IGH rearrangement with D-S states(r=0.434,P=0.007),or between the deletion of p53 with IIS states(r=-0.448,P=0.006),or between the D13S319 deletion with immunological types(r=-0.335,P=0.040).Conclusion The familiar genetic abnormality of MM include lq21 amplification,13q14 deletion,p53 gene deletion and IGH gene rearrangement,and FISH is a helpful technique to explore the relationship between chromosome aberrations with development and prognosis.
出处 《中国医药科学》 2012年第1期12-14,45,共4页 China Medicine And Pharmacy
基金 卫生部科研基金课题(WKJ2007-3-001)
关键词 多发性骨髓瘤 荧光原位杂交 染色体畸变 Multiple myeloma; Fluorescence in situ hybridization; Chromosome aberration;
  • 相关文献

参考文献11

  • 1中国多发性骨髓瘤诊治指南[J].中华内科杂志,2008,47(10):869-872. 被引量:88
  • 2罗绍凯,苏畅,王晓桃,李娟.102例多发性骨髓瘤临床资料分析[J].临床血液学杂志,2008,21(2):115-116. 被引量:12
  • 3Shaughnessy J,Zhan F,Burington B,et a1.A validated gene expression modelof hIGH-risk multiple myeloma is defined by disregulated expression of genesmapping chromosome 1[J].Blood,2007,109(6):2276-2284.
  • 4Zhan F,Colla S,Wu X,et a1.CKSlB,overexpressed in aggressive disease,regulatesmultiple myeloma growth and survival through SKP2-and p27Kipl-dependent andindependentmechanisms[J].Blood,2007,109(11):4995-5001.
  • 5Shaughnessy J.Amplification and overexpression of CKS1B at chromosome bandlq21 is associated with reduced levels of p27 and an aggressive clinical coursein multiple myeloma[J].Hematology,2005,10(suppl 1):117-126.
  • 6Chng WJ,Van Wier SA,Ahmann GJ,et al.A validated FISH trisomy indexdemonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS[J].Blood,2005,106(6):2156-2161.
  • 7杨瑞芳,李春溟,陈丽娟,仇海荣,杨慧,刘澎,许家仁,李建勇.荧光原位杂交技术检测多发性骨髓瘤分子遗传学改变及其意义[J].中华医学遗传学杂志,2010,27(5):567-570. 被引量:6
  • 8Saughnessy J,Tian E,Sawyer J,et a1.High incidence of chromosome 13deletion in multiple myeloma detected by multiprobe interphase FISH[J].Blood,2000,96(4):1505.
  • 9Facon T,Aver-Leiseau H,Guillerm G,et a1.Chromosome 13 abnormaliiesidentified by FISH analysis and serum β2-microglobulin produce a powerfulmyeloma staging system for patients receiving hIGH-dose therapy[J].Blood,2001,97(6):1561-1577.
  • 10Jens H,Christian MZ,Andreas N,et a1.Gain of lq21 and distinct adversecytogenetic abnormalities correlate with increased microcirculation in multiplemyeloma[J].Int J Cancer,2008,122(12):2871-2875.

二级参考文献8

  • 1ALEXANDRAKIS M G, PASSAM F H, MALLIARAKI N. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeioma patients[J]. Clinica Chimi ca. Acta,2002,325:51--57.
  • 2JACOBSON J L, HUSSEIN M A, BARI.OGIE B,et al. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience[J]. Br J Haematol, 2003,122,441 --450.
  • 3LENTZSCH S, GRIES M, JANZ M, et al. macroPhage inflammatory Protein-1αtriggers migration and signaling cascades mediating survival and Proliferation in multiPle myeloma cells[J]. Blood ,2003,101 : 3568-- 3573.
  • 4DIMOPOULOS M A, ZERVAS K, POUI.I A, et al. Indepent validation of the Southwest Oncology Group (SWOG) staging system: a clinically useful staging system for multiple myeloma [J ]. Blood, 100,2361- 2367.
  • 5KYLE R A,GERTZ M A,WITZIG T E. Review of 1027 patients with newly diagnosed multiple myeloma [J]. Mayo Clin Proc,2003,78:21--23.
  • 6Jie Zhang,Reiko Ito,Naohide Oue,Xudong Zhu,Yasuhiko Kitadai,Kazuhiro Yoshida,Hirofumi Nakayama,Wataru Yasui. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma[J] 2003,Virchows Archiv(6):563~568
  • 7万理萍,孙汉英,刘文励.多发性骨髓瘤预后因素分析[J].临床血液学杂志,1999,12(6):281-283. 被引量:5
  • 8葛祥花.多发性骨髓瘤患者血清β_2-微球蛋白、C反应蛋白水平的测定及临床意义[J].临床血液学杂志,2003,16(5):242-243. 被引量:18

共引文献103

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部